5298.0: Wednesday, November 15, 2000: 8:30 PM-10:00 PM | ||||
| ||||
| Developments in health care characterized by a transition to managed care models, represent dramatic systemic efforts to increase access to treatment, including substance abuse treatment. But innovation has occurred primarily in the private sector: models of change for publicly funded drug abuse treatment have emerged only recently. One innovation in the public sector has been the concept of “Treatment on Demand” (TOD), a health care system that provides appropriate and prompt treatment services “on demand” to alcohol or other drug dependent individuals. Since 1997 at least four communities have allocated resources to the implementation of TOD by increasing access to treatment, improving social and health outcomes, reducing waiting periods, and providing a continuum of integrated services. The San Francisco community has also included a program evaluation to assess how and the extent to which these Treatment on Demand initiatives improved access to treatment. This panel will describe an innovative approach to Treatment on Demand in San Francisco, research and evaluation strategies, and findings to date. The overall objective is to describe the San Francisco Treatment on Demand program and to report the effects of Treatment on Demand in terms of treatment access, system capacity and utilization, as well as treatment waiting lists and the perspective of community leaders and substance abusers seeking treatment | ||||
| See individual abstracts for presenting author's disclosure statement. | ||||
| Learning Objectives: Refer to the individual abstracts for learning objectives | ||||
| Randolph Muck Alice A. Gleghorn, PhD | ||||
| Joseph Guydish, PhD Sandra Nuñez, BA | ||||
| "Treatment on Demand Initiative": The impact on social and health outcomes among injection drug users in San Francisco, CA, 1998-1999 Ricky N. Bluthenthal, PhD, Lauren Gee, Jeffry Moore, Alice A. Gleghorn, PhD, Elita Hagos, Brian R. Edlin, MD | ||||
| Evaluating "Treatment on Demand" in San Francisco: Do waiting lists contract? James L. Sorensen, PhD, Marvin Jacoby | ||||
| Process evaluation of "Treatment on Demand" in San Francisco: The first steps Lisa D. Moore, PhD, Beatrice Sanchez, John Harcourt | ||||
| Readiness to stop drug use: Prevalence and predictive value of a stage-of-change model among injection drug users Leigh A. Henderson, PhD, David Vlahov, PhD, David Celentano, ScD | ||||
| San Francisco "Treatment on Demand": Effects on capacity and utilization Joseph Guydish, PhD, Alice A. Gleghorn, PhD, Thomas Davis, Sandra Nuñez | ||||
| Sponsor: | Alcohol, Tobacco, and Other Drugs | |||
| Cosponsors: | Caucus on Homelessness; Lesbian, Gay, Bisexual, and Transgender Caucus of Public Health Workers; Mental Health | |||